Benitec Appoints two new Directors
News Feb 13, 2006
Benitec Ltd. has announced that it has appointed Peter Francis as a Non-executive Director and Michael Catelani as an Executive Director of its Board.
Mr. Peter Francis is a partner at Francis Abourizk Lightowlers (FAL), a firm of commercial and technology lawyers with offices in Melbourne and Brisbane, Australia.
He is a legal specialist in the areas of intellectual property and licensing and provides legal advice to a large number of corporations and research bodies.
Mr. Francis has extensive experience in technology commercialization and is a founder and Non-executive Director of Boron Molecular Pty Ltd. and a Non-executive Director of Xceed Biotechnology Ltd and PolyNovo Pty Ltd.
Mr. Michael Catelani joined Benitec as its Chief Financial Officer in April 2005 after having served in that capacity as a consultant to the company since January 2005.
During his tenure at Benitec, Mr. Catelani has been instrumental in developing and executing strategic objectives such as fundraising, operational and financial consolidation, compliance, and corporate governance, as well as playing a key role in establishing the company's strategic alliance with Sigma-Aldrich.
Prior to joining Benitec, Mr. Catelani held senior financial management positions, including Vice President and Chief Financial Officer, at Axon Instruments, a U.S. corporation listed on the Australian Stock Exchange and a leading designer and manufacturer of instrumentation and software systems for the life sciences industry.
At Axon, Mr. Catelani played a significant role in the company's merger with Molecular Devices Corporation, a NASDAQ listed company. Mr. Catelani began his professional career at Ernst & Young and is a CPA. He has an MBA from the University of California, Davis.
Ray Whitten, Executive Chairman of Benitec, stated, "I am looking forward to the significant contributions that our newest directors will be making to Benitec."
"Peter and Mike possess expertise that will be invaluable in further developing and executing Benitec's strategic goals."
Back in 2009, researchers identified a herd of Awassi sheep suffering from "day blindness". As that term implies, these sheep were blind during the day (in bright light) but could see at night, in low-light conditions. After identifying the genetic basis of this blindness, researchers have now successfully used gene therapy to restore their daytime vision.READ MORE